and appetite suppressants, depending on the specific product and its safety profile.
Some medications or treatments used during the COVID-19 pandemic have also been subject to safety monitoring, although the risks and evidence differ substantially between individual products.
Regulatory authorities, including national medicines agencies and international health organizations, may issue safety communications, restrictions, recalls, or other measures when evidence indicates a potential risk. A medication being monitored does not necessarily mean that every person taking it faces the same level of risk.
Who May Have a Higher Risk?
The likelihood of cardiovascular complications can be influenced by individual health factors and medical history. Factors that may be relevant include:
High blood pressure
Obesity
Diabetes
Smoking
A personal or family history of blood clots or certain inherited clotting conditions
Other factors, such as age, previous cardiovascular disease, surgery, prolonged immobility, pregnancy, and other medications, may also affect risk depending on the
